Ondansetron
- 1 June 1993
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 3 (6) , 471-481
- https://doi.org/10.2165/00019053-199303060-00007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group studyBritish Journal of Cancer, 1992
- Medical Care and Cost Outcomes After Pentoxifylline Treatment for Peripheral Arterial DiseaseArchives of internal medicine (1960), 1992
- Using Health Status Measures in the Hospital SettingMedical Care, 1992
- Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast CancerOncology, 1992
- A layman's guide to the U.S. health care system1992
- Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyThe Lancet, 1991
- OndansetronDrugs, 1991
- Tight margins lead hospitals to cost accounting systems.1990
- Review: The Management of Nausea and Vomiting in Clinical OncologyThe Lancet Healthy Longevity, 1987
- Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.Journal of Clinical Oncology, 1984